Bibliografia UJ CM

1/6
Nina D. Wagner-Johnston, Stephen J. Schuster, Sven deVos, Gilles Salles, Wojciech Jurczak, Christopher R. Flowers, Andreas Viardot, Ian W. Flinn, Peter Martin, Guan Xing, Nishanthan Rajakumaraswamy, Ajay K. Gopal.
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas.
Leukemia & Lymphoma
2021 : Vol. 62, nr 5, s. 1077-1087, bibliogr., abstr.
Autor korespondencyjny: Nina D. Wagner-Johnston
p-ISSN: 1042-8194
AZ
ORG
AIF
IF: 2.996
Adres url:
Streszczenie w PubMed:
DOI:
2/6
Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, Chan Y. Cheah, John M. Pagel, Jennifer A. Woyach, Bita Fakhri, Toby A. Eyre, Nicole Lamanna, Manish R. Patel, Alvaro Alencar, Ewa Lech-Maranda, William G. Wierda, Catherine C. Coombs, James N. Gerson, Paolo Ghia, Steven Le Gouill, David John Lewis, Suchitra Sundaram, Jonathon B. Cohen, Ian W. Flinn, Constantine S. Tam, Minal A. Barve, Bryone Kuss, Justin Taylor, Omar Abdel-Wahab, Stephen J. Schuster, M. Lia Palomba, Katharine L. Lewis, Lindsey E. Roeker, Matthew S. Davids, Xuan Ni Tan, Timothy S. Fenske, Johan Wallin, Donald E. Tsai, Nora C. Ku, Edward Zhu, Jessica Chen, Ming Yin, Binoj Nair, Kevin Ebata, Narasimha Marella, Jennifer R. Brown, Michael Wang.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN) : a phase 1/2 study.
Lancet
2021 : Vol. 397, nr 10277, s. 892-901, il., bibliogr. 30 poz., sum.
Autor korespondencyjny: Anthony R. Mato.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 202.731
Adres url:
Streszczenie w PubMed:
3/6
Ajay K. Gopal, Stephen J. Schuster, Nathan H. Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Andrew Spencer, John Radford, Wojciech Jurczak, James Morton, Dolores Caballero, Sanjay Deshpande, Gary J. Gartenberg, Shean-sheng Wang, Rajendra N. Damle, Michael Schaffer, Sriram Balasubramanian, Jessica Vermeulen, Bruce D. Cheson, Gilles Salles.
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.
Journal of Clinical Oncology
2018 : Vol. 36, nr 23, s. 2405-2412
Autor korespondencyjny: Ajay K. Gopal.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 28.245
Adres url:
Streszczenie w PubMed:
DOI:
4/6
Gilles Salles, Stephen J. Schuster, Sven de Vos, Nina D. Wagner-Johnston, Andreas Viardot, Kristie A. Blum, Christopher R. Flowers, Wojciech J. Jurczak, Ian W. Flinn, Brad S. Kahl, Peter Martin, Yeonhee Kim, Sanatan Shreay, Matthias Will, Bess Sorensen, Madlaina Breuleux, Pier Luigi Zinzani, Ajay K. Gopal.
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study.
Haematologica
2017 : Vol. 102, nr 4, s. e156-e159, il., bibliogr., abstr.
Open Access Creative Commons Attribution License CC-BY.
Autor korespondencyjny: Ajay K. Gopal.
Data udostępnienia w sposób otwarty: 2016-12-15
p-ISSN: 0390-6078
AZ
ORG
AIF
IF: 9.090
BB: PubMed ; Scopus ; Web of Science Core Collection
PubMed; Scopus; Web of Science Core Collection
Adres url:
Streszczenie w PubMed:
5/6
Ajay K. Gopal, Stephen J. Schuster, Nathan Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Wojciech Jurczak, James Morton, Dzhelil Osmanov, Gary J. Gartenberg, Jessica Vermeulen, Sriram Balasubramanian, Shean-sheng Wang, Sanjay Deshpande, Gilles A. Salles.
Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DAWN Study.
Blood
2016 : Vol. 128, nr 22, s. 1217
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
6/6
Ajay K. Gopal, Brad S. Kahl, Sven Vos, de, Nina D. Wagner-Johnston, Stephen J. Schuster, Wojciech J. Jurczak, Ian W. Flinn, Christopher R. Flowers, Peter Martin, Andreas Viardot, Kristie A. Blum, Andre H. Goy, Andrew J. Davies, Pier Luigi Zinzani, Martin Dreyling, Dave Johnson, Langdon L. Miller, Leanne Holes, Daniel Li, Roger D. Dansey, Wayne R. Godfrey, Gilles A. Salles.
PI3KΔ inhibition by idelalisib in patients with relapsed indolent lymphoma.
New England Journal of Medicine
2014 : Vol. 370, nr 11, s. 1008-1018, il., bibliogr., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 55.873
Adres url:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ